Simone Baldoni

Simone Baldoni

Auto-generated profile, based on publicly available information

Simone Baldoni

Telemedicine and Telepharmacy Center, School of Medicinal and Health Products Sciences, University of Camerino. Camerino (Italy).

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2019 in Medicina
Verified
Journal Article
Open access
PDF file
SBSimone Baldoni
Simone Baldoni
Francesco AmentaFrancesco Amenta
Francesco Amenta
Giovanna RicciGiovanna Ricci
Giovanna Ricci
Background and Objectives: The term “telepharmacy” indicates a form of pharmaceutical care in which pharmacists and patients are not in the same place and can interact using information and communication technology (ICT) facilities. Telepharmacy has been adopted to provide pharmaceutical services to underserved areas and to address the problem of pharmacist shortage. This paper has reviewed the multi-faceted phenomenon of telepharmacy, summarizing different experiences in the area. Advantages and limitations of telepharmacy are discussed as well. Materials and Methods: A literature analysis was carried out on PubMed, using as entry term “telepharmacy” and including articles on the topic published between 2012 and 2018. Results: The studies reviewed were divided into three categories of pharmacy practice, namely (1) support to clinical services, (2) remote education and handling of “special pharmacies”, and (3) prescription and reconciliation of drug therapies. In general, different telepharmacy services were effective and accompanied by a satisfaction of their targets. Conclusions: Nowadays, the shortage of health personnel, and in particular pharmacists, is a challenging issue that the health systems have to face. The use of a new technology such as telepharmacy can represent a possible option to solve these problems. However, there are unsolved limitations (e.g., legal implications) that make greater diffusion of telepharmacy difficult. Stronger data on the effectiveness of this area of pharmacy care, together with a critical evaluation of its limits, can make actors involved aware about the potentialities of it and could contribute to a larger diffusion of telepharmacy services in the interest of communities and citizens.

1 September 2018 in Ageing Research Reviews
Verified
Journal Article
Closed access
FGFelicia Gurău
Felicia Gurău
SBSimone Baldoni
Simone Baldoni
FPFrancesco Prattichizzo
Francesco Prattichizzo
EEEmma Espinosa
Emma Espinosa
FAFrancesco Amenta
Francesco Amenta
FOFabiola Olivieri
Fabiola Olivieri

17 July 2020 in Pharmacy Practice
Verified
Journal Article
Open access
PDF file
SBSimone Baldoni
Simone Baldoni
GPGraziano Pallotta
Graziano Pallotta
ETEnea Traini
Enea Traini
GSGetu Sagaro
Getu Sagaro
GNGIULIO NITTARI
GIULIO NITTARI
Francesco AmentaFrancesco Amenta
Francesco Amenta
Background: Telemedicine is defined as “the use of medical information exchanged from one site to another via electronic communications to improve a patient’s health status”. This relatively new concept of healthcare is based on the fusion between medical assistance and Information and Communication Technology (ICT) to provide support to people located in remote and underserved areas. It can be found not only in hospitals, but also in other healthcare facilities such as pharmacies. Starting from 2010, telemedicine or telehealth was formally introduced in the Italian pharmaceutical context with the "Pharmacy of Services Decree". In spite of this regulatory framework, the implementation of this technology was very slow and there are no data about the spreading and use of these services in Italian pharmacies. Objective: The present study has therefore developed a survey to collect information on the diffusion of telemedicine/telehealth services within Italian pharmacies. Methods: A two-part questionnaire in Italian was developed using SurveyMonkey, setting a mechanism aimed to have different outcomes according to the answers given. Six hundred eighty-three respondents returned the questionnaire. The results were then analysed statistically. Results: The questionnaire results have shown a limited diffusion of telemedicine/telehealth services among Italian pharmacies and an apparently limited interest of health authorities in supporting the integration of this technology. Conclusions: More efforts should be spent by national public health stakeholders to better analyse the contribution of telemedicine services available in public pharmacies and to find the best solutions to implement this innovative technology as an established service.